Contenido principal del artículo

Carlos Enrique Trillos Peña

La pandemia por covid-19 es uno de los episodios de la historia reciente y presente de la humanidad que se ha  caracterizado por ser de los más amenazantes de los últimos tiempos, con más de 500 millones de casos confirmados y 6.3 millones de fallecimientos al 30 de abril de 2022, con cuatro grandes picos en todo el mundo (1,2). Estas cifras pueden
ser mucho más altas si se tiene en cuenta el subregistro en algunas partes del planeta. De acuerdo con la publicación del  Grupo de Colaboradores de Exceso de Mortalidad por covid-19 en The Lancet, en marzo de 2022, se calcula que las muertes por la pandemia son tres veces las publicadas oficialmente, con una estimación del 1.º de enero de 2020 al 31 de diciembre de 2021 en 191 países, de 18.2 millones muertes vs. los 5.9 millones de fallecimientos para ese periodo (3). De aquí que la primera reflexión está relacionada con el subregistro, que es alto y distorsiona la magnitud del problema, por lo que posiblemente algunos no le han dado la relevancia que merece.

Descargas

Los datos de descargas todavía no están disponibles.
Trillos Peña, C. E. . (2022). COVID-19: un maestro para la humanidad. Revista Ciencias De La Salud, 20(2). Recuperado a partir de https://revistas.urosario.edu.co/index.php/revsalud/article/view/11973

Worldometer. covid-19 coronavirus pandemic [internet]. 2022 [citado 2022 abr 30]. Disponible en: https://www.worldometers.info/coronavirus/

John Hopkins University of Medicine Coronavirus Resource Center. COVID-19 map [internet]. 2022 [citado 2022 abr 30]. Disponible en: https://coronavirus.jhu.edu/map.html

Wang H, Paulson KR, Pease SA, Watson S, Comfort H, Zheng P, et al. Estimating excess mortality due to the covid-19 pandemic: a systematic analysis of covid-19-related mortality, 2020-21. Lancet. 2022;399(10334):1513-36. https://doi.org/10.1016/S0140-6736(21)02796-3

Organización Mundial de la Salud. Seguimiento de las variantes del SARS-CoV-2 [internet]. 2022 [citado 2022 abr 30]. Disponible en: https://www.who.int/es/activities/tracking-SARS-CoV-2-variants

Duek I, Fliss DM. The covid-19 pandemic – from great challenge to unique opportunity: Perspective. Ann Med Surg. 2020;59:68-71. https://doi.org/10.1016/j.amsu.2020.08.037

Nextstrain Team, gisaid. Genomic epidemiology of SARS-CoV-2 with susmapling focused globally over the past 6 months [internet]. 2022 [citado 2022 abr 30]. Disponible en: https://nextstrain.org/ncov/gisaid/global/6m

Ou J, Lan W, Wu X, Zhao T, Duan B, Yang P, et al. Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events. Signal Transduct Target Ther. 2022;7(138). https://doi.org/10.1038/s41392-022-00992-2

DeGrace MM, Ghedin E, Frieman MB, Krammer F, Grifoni A, Alisoltani A, et al. Defining the risk of SARS-CoV-2 variants on immune protection. Nature. 2022. https://doi.org/10.1038/s41586-022-04690-5

Fundeú RAE. “Sindemia”, término válido [internet]. 2020 [citado 2022 abr 30]. Disponible en: https://www.fundeu.es/recomendacion/sindemia-termino-valido/

Fronteira I, Sidat M, Magalhães JP, de Barros FPC, Delgado AP, Correia T, et al. The SARSCoV-2 pandemic: A syndemic perspective. One Health;12:100228. https://doi.org/10.1016/j.onehlt.2021.100228

Rewerska-Juśko M, Rejdak K. Social stigma of patients suffering from covid-19: challenges for health care system. Healthcare. 2022;10(2):292. https://doi.org/10.3390/health care10020292

Tsai AC. Syndemics: a theory in search of data or data in search of a theory? Soc Sci Med. 2018;206:117-22. https://doi.org/10.1016/j.socscimed.2018.03.040

Singer M, Bulled N, Ostrach B, Mendenhall E. Syndemics and the biosocial conception of health. Lancet. 2017;389(10072):941-50. https://doi.org/10.1016/S0140-6736(17)30003-X

Singer M, Clair S. Syndemics and public health: reconceptualizing disease in bio-social context. Med Anthropol Q. 2003;17(4):423-41.

Pryor S, Dietz W. The covid-19, obesity, and food insecurity syndemic. Curr Obes Rep. 2022. https://doi.org/10.1007/s13679-021-00462-w. Online ahead of print.

Oliu-Barton M, Pradelski BSR, Algan Y, Baker MG, Binagwaho A, Dore GJ, et al. Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines. Lancet Glob Health. 2022;10(1):e142-7. https://doi.org/10.1016/S2214-109X(21)00494-0

Resolve to Salve Lives, Vital Strategies. Manual de estrategias para la covid-19. Coronavirus. 2020 oct [internet]. 2020. Disponible en: https://preventepidemics.org/wp-content/ uploads/2020/05/COVID19Playbook_Spanish.pdf

Lewis D. Superspreading drives the covid pandemic — and could help to tame it. Nature. [internet]. 2021 feb 23 [citado 2022 may 2];590(7847):544-6. Disponible en: https://www.nature.com/articles/d41586-021-00460-x

Wu C, Xu C, Mao F, Xu X, Zhang C. The impact of invisible-spreaders on covid-19 transmission and work resumption. Plos One. 2022;17(1):e0252994. https://doi.org/10.1371/journal.pone.0252994

Liu Y, Yu Q, Wen H, Shi F, Wang F, Zhao Y, et al. What matters: non-pharmaceutical interventions for covid-19 in Europe. Antimicrob Resist Infect Control. 2022;11(1):3. https://doi.org/10.1186/s13756-021-01039-x

Zildzic M, Salihefendic D, Masic I. Non-pharmacological measures in the prevention and treatment of covid-19 infection. Med Arch. 2021;75(4):307-12. https://doi.org/10.5455/medarh.2021.75.307-312

Oraby T, Tyshenko MG, Maldonado JC, Vatcheva K, Elsaadany S, Alali WQ, et al. Modeling the effect of lockdown timing as a covid-19 control measure in countries with differing social contacts. Sci Rep. 2021;11(1):3354. https://doi.org/10.1038/s41598-021-82873-2

Goult E, Sathyendranath S, Kovač Ž, Kong CE, Stipanović P, Abdulaziz A, et al. Analysis of non-pharmaceutical interventions and their impacts on covid-19 in Kerala. Sci Rep. 2022;12(1):584. https://doi.org/10.1038/s41598-021-04488-x

Covid research: a year of scientific milestones. Nature. [internet]. 2021 may 5 [citado 2022 may 1]. Disponible en: https://www.nature.com/articles/d41586-020-00502-w

Haleem A, Javaid M, Vaishya R, Deshmukh SG. Areas of academic research with the impact of covid-19. Am J Emerg Med. 2020;38(7):1524-6. https://doi.org/10.1016/j.ajem.2020.04.022

Norton A, Bucher A, Antonio E, Advani N, Johnston C, Grund H, et al. A living mapping review for covid-19 funded research projects: one year update. Wellcome Open Res. 2022 5:209. https://doi.org/10.12688/wellcomeopenres.16259.5

Tatar M, Wilson FA. The largest vaccination campaign in history: a golden opportunity for bundling public health interventions. J Glob Health. 2021;11:03076. https://doi.org/10.7189/jogh.11.03076

Callaway E. The race for coronavirus vaccines: a graphical guide. Nature [internet]. 2020 [citado 2022 may 1];580(7805):576-7. Disponible en: https://www.nature.com/articles/d41586-020-01221-y

Organización Mundial de la Salud. who-covid19 vaccine tracker [internet]. 2022 [citado 2022 may 1]. Disponible en: https://covid19.trackvaccines.org/agency/who/

Ritchie H, Mathieu E, Rodés-Guirao L, Appel C, Giattino C, Ortiz-Ospina E, et al. Coronavirus pandemic (covid-19). Our World Data [internet]. 2022 abr 30 [citado 2022 abr 30]. Disponible en: https://ourworldindata.org/covid-vaccinations

Jabłońska K, Aballéa S, Toumi M. The real-life impact of vaccination on covid-19 mortality in Europe and Israel. Public Health. 2021;198:230-7. https://doi.org/10.1016/j.puhe.2021.07.037

Chen X, Huang H, Ju J, Sun R, Zhang J. Impact of vaccination on the covid-19 pandemic in U.S. states. Sci Rep [internet]. 2022 [citado 2022 may 1];12(1):1554. Disponible en: https://www.nature.com/articles/s41598-022-05498-z

Moghadas SM, Vilches TN, Zhang K, Wells CR, Shoukat A, Singer BH, et al. The impact of vaccination on coronavirus disease 2019 (covid-19) outbreaks in the United States. Clin Infect Dis. 2021;73(12):2257-64. https://doi.org/10.1093/cid/ciab079

Andrews N, Stowe J, Kirsebom F, Toffa S, Rickeard T, Gallagher E, et al. Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant. N Engl J Med. 2022;386(16):1532-46. https://doi.org/10.1056/NEJMoa2119451

Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (covid-19): A review. JAMA. 2020;323(18):1824-36. https://doi.org/10.1001/jama.2020.6019

Zimmer PC, Wu KJ, Corum J, Kristoffersen M. Tratamientos y medicamentos para el coronavirus: monitoreo de efectividad. The New York Times [internet]. 2020 jul 16 [citado 2022 may 2]. Disponible en: https://www.nytimes.com/es/interactive/2020/science/coronavirus-tratamientos-curas.html

Craven J. Covid-19 therapeutics tracker [internet]. Regulatory Affairs Professional Society. [internet] 2022 [citado 2022 may 2]. Disponible en: https://www.raps.org/news-and-articles/news-articles/2020/3/covid-19-therapeutics-tracker

Fundéu RAE. “Infodemia”, neologismo válido [internet]. 2020 [citado 2022 may 2]. Disponible en: https://www.fundeu.es/recomendacion/infodemia/

Gallotti R, Valle F, Castaldo N, Sacco P, De Domenico M. Assessing the risks of “infodemics” in response to covid-19 epidemics. Nat Hum Behav [internet]. 2020 [citado 2022 may 2];4(12):1285-93. Disponible en: https://www.nature.com/articles/s41562-020-00994-6

Saher R, Anjum M. Role of technology in covid-19 pandemic. Res Appl Artif Intell Mitigate Pandemics. 2021;109-38. https://doi.org/10.1016/B978-0-323-90959-4.00005-5

Shah S, Diwan S, Kohan L, Rosenblum D, Gharibo C, Soin A, et al. The technological impact of covid-19 on the future of education and health care delivery. Pain Physician. 2020;23(4S):S367-80.

Nature Electronics. Digital tech and the pandemic. Nat Electron [internet]. 2021 [citado 2022 may 1];4(1):1-1. Disponible en: https://www.nature.com/articles/s41928-021-00539-3

Phillips S, Williams MA. Confronting our next national health disaster — long-haul covid. N Engl J Med. 2021;385(7):577-9. https://doi.org/10.1056/NEJMp2109285

Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute covid-19 syndrome. Nat Med [internet]. 2021 [citado 2022 may 2];27(4):601-15. Disponible en: https://www.nature.com/articles/s41591-021-01283-z

Brodin P, Casari G, Townsend L, O’Farrelly C, Tancevski I, Löffler-Ragg J, et al. Studying severe long covid to understand post-infectious disorders beyond covid-19. Nat Med [internet]. 2022 [citado 2022 may 2];1-4. Disponible en: https://www.nature.com/articles/s41591-022-01766-7

Katzourakis A. covid-19: endemic doesn’t mean harmless. Nature [internet]. 2022 [citado 2022 may 2];601(7894):485. Disponible en: https://www.nature.com/articles/d41586-022-00155-x

Grange ZL, Goldstein T, Johnson CK, Anthony S, Gilardi K, Daszak P, et al. Ranking the risk of animal-to-human spillover for newly discovered viruses. Proc Natl Acad Sci. 2021;118(15):e2002324118. https://doi.org/10.1073/pnas.2002324118

Lawler OK, Allan HL, Baxter PWJ, Castagnino R, Tor MC, Dann LE, et al. The covid-19 pandemic is intricately linked to biodiversity loss and ecosystem health. Lancet Planet Health. 2021;5(11):e840-50. https://doi.org/10.1016/S2542-5196(21)00258-8

Assefa Y, Gilks CF, Reid S, van de Pas R, Gete DG, Van Damme W. Analysis of the covid-19 pandemic: lessons towards a more effective response to public health emergencies. Glob Health. 2022;18(1):10. https://doi.org/10.1186/s12992-022-00805-9

Have H ten. Global bioethics: an introduction. London: Routledge, Taylor & Francis Group; 2016.

Detalles del artículo

Artículos más leídos del mismo autor/a